ORTEXORTEX News
Tracking FIG? Get live short interest, options flow, and signals on ORTEX.Sign up free →
FI
Earnings PreviewFIG

Figma's 12% Slide Leaves It Trailing Peers Into Tuesday's Print

By ORTEX News · Edited by , Editor, ORTEX News2 min readdata as of 1 Nov 2026, 04:05

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

FIG dropped 12.1% in the past week to $21.65, nearly double the median decline of 5.1% across its closest software peers. ADBE fell 5.2% over the same period, FRSH 5.0%, and MNDY 10.3%, but HUBS matched Figma's pain at 13.3%. The underperformance is not isolated to Figma, but the stock's year-to-date loss of roughly 38% makes the gap against peers more consequential heading into Tuesday's results.

Short sellers have been adding to positions into the selloff, not covering. Short interest climbed 10.7% over the past week to 8.7% of the free float, reversing a month-long reduction that had brought the figure down from above 10%. The recent bounce in short positions is notable against the backdrop of a stock already under pressure, though borrow conditions do not point to a disorderly squeeze: cost to borrow is just 0.43% and availability is ample at 456%, meaning there are roughly four and a half shares available to lend for every one currently shorted. Options positioning offers no strong directional signal either, with the put/call ratio at 0.52, almost exactly in line with its 20-day average and well off the 52-week defensive peak of 0.82.

The debate among analysts has tilted cautious. Citigroup trimmed its target to $35 from $37 on October 28 while holding its Buy rating. Wells Fargo and Stifel both cut targets earlier in the month. The consensus target of $29.90 implies 38% above the current price, but the direction of recent moves has been downward, not upward. The bull case rests on Figma's enterprise entrenchment: 690,000 paying customers as of March 2026, 132% net revenue retention for accounts above $10,000, and an AI expansion layer through Make, Dev Mode and the Figma Agent that has yet to fully monetize. The bear case is a narrower near-term window: third-quarter guidance implied a sequential revenue step-up of only $3 million to $5 million, the smallest since the IPO, while AI inference costs are pushing gross margins from above 92% in 2024 toward the low-80s by the end of this year. The EPS surprise factor score ranks in just the 4th percentile, meaning the company has rarely beaten estimates, which limits the cushion for a miss.

One ownership dynamic worth noting: CEO Dylan Field holds a Schedule 13D filing on the register, marking him as an activist-classified holder with a 15.0% stake as of his last disclosure in June 2026, down from 16.9% previously. Greylock trimmed its position by 13.1 million shares in its most recent report. Insider activity over the past 90 days has been net negative at roughly $17 million sold, though all recent open-market sales were executed under pre-arranged 10b5-1 plans, reducing their signalling weight. Wikipedia attention for Figma is running at a z-score of 3.2 against its own 90-day history, a sharp spike in retail interest that has coincided with the price decline rather than preceded a recovery.

Tuesday's print is primarily a test of whether the sequential revenue trajectory has stabilised above that $3 million to $5 million step-up floor, and whether gross margin guidance for year-end 2026 is narrowing or widening from the 92%-to-low-80s compression range the Street is already modelling.

Stocks in this article

See the live data behind this article on ORTEX.

Open FIG on ORTEX →

How this article was generated

Generated
1 Nov 2026, 04:28
Data as of
1 Nov 2026, 04:05
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.